Evidence-Based Medicine Guidelines
Cholinesterase inhibitors for mild cognitive impairment
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cholinesterase Inhibitors for Mild Cognitive Impairment." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458192/all/Cholinesterase_inhibitors_for_mild_cognitive_impairment.
Cholinesterase inhibitors for mild cognitive impairment. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458192/all/Cholinesterase_inhibitors_for_mild_cognitive_impairment. Accessed December 3, 2023.
Cholinesterase inhibitors for mild cognitive impairment. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458192/all/Cholinesterase_inhibitors_for_mild_cognitive_impairment
Cholinesterase Inhibitors for Mild Cognitive Impairment [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 December 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458192/all/Cholinesterase_inhibitors_for_mild_cognitive_impairment.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cholinesterase inhibitors for mild cognitive impairment
ID - 458192
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458192/all/Cholinesterase_inhibitors_for_mild_cognitive_impairment
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
